MS Society Funds 3 New Investigations into Symptom Management
The Multiple Sclerosis Society (MS Society) in the U.K. recently announced awards targeted towards new MS research. In total, 16 projects…
Articles by Patricia Silva, PhD
MS Patients on Salt-heavy Diets Risk Inflammation
Findings from two studies, recently published in the Journal of Clinical Investigation, indicate that high levels of…
MS Society Supports 2 Projects Advancing MS Care, Services
The United Kingdom based Multiple Sclerosis Society (MS Society) recently announced £1.98 million in grants to new MS research projects in…
MS Society Funds 5 Projects Aiming to Cure the Disease
The Multiple Sclerosis Society (MS Society) in the United Kingdom recently announced the investment of £1.98 million in…
Might Chocolate Ease Multiple Sclerosis Fatigue?
A research team from Oxford Brookes University is being given a £70,000 ($107,000) grant to analyze whether dark chocolate can help…
MS Society Invests in Research into Underlying Causes of Disease
The Multiple Sclerosis Society (MS Society) in the United Kingdom recently announced the investment of £1.98 million in…
Autoimmune Disease Researcher Honored with Sanofi-Institut Pasteur Award
Sanofi, a global healthcare leader, and the Institut Pasteur, an internationally renowned center for biomedical research, recently honored four…
Mitsubishi Auction Raises Money for Multiple Sclerosis Society
Mitsubishi Motors North America, Inc. (MMNA) recently announced a nationwide auction of its first Mitsubishi Lancer Evolution Final Edition to raise…
MS Patients and Doctors Have a New Way of Working Together
A new partnership between ARM and HeartToHeart Networks LLC has brought healthcare providers of patients with neurodegenerative disorders, such as…
Roche to Pursue MS Ocrelizumab Drug Market Authorization
Roche recently provided an update on their late-stage pipeline products across several therapeutic areas, including ocrelizumab for the treatment of…
National Multiple Sclerosis Society Invests Over $21 Million to Fund New MS Research
The National Multiple Sclerosis Society has dedicated over $21 million to fund 78 new multiple sclerosis (MS) research studies as part…
MS, Other Groups to Benefit from Fitbit’s Step Challenge
Fitbit, a company dedicated to the development of health and fitness products and experiences to help individuals adopt healthier lifestyles,…
MS Study of Smartphone Self-Evaluation Shows Limitations and Potential
A smartphone platform may eventually enable large-scale studies of patients with multiple sclerosis (MS) or other neurologic diseases, according to…
MS Patients May Be More Fit Than Tests Indicate
Findings from a recent study published in the Journal of Neurologic Physical Therapy showed that standard approaches…
Autoimmune Disease, Obesity Link Found in Subset of Immune Dendritic Cells
In a recent study published in the journal Immunity, researchers at the Weizmann Institute of Science…
Alkermes’ Multiple Sclerosis Therapy ALKS 8700 Yields Positive Clinical Trial Data
Alkermes plc, a fully integrated global biopharmaceutical company, recently provided a regulatory update and positive clinical trial data for…
Psychiatric Comorbidity Among Multiple Sclerosis Patients Reported to Be Common
Psychiatric comorbidity is common in patients with multiple sclerosis (MS), and affects the MS community more frequently than a matched control…
Multiple Sclerosis Pilot Study Evaluating PoNS Yields Promising Results
Helius Medical Technologies, Inc., a company dedicated to neurological wellness, recently announced that the multiple sclerosis (MS) pilot…
OCT Collaborators Win 2015 Barancik Prize for Innovation in MS Research
A collective team of physician-researchers comprising Dr. Peter Calabresi from Johns Hopkins School of Medicine in Baltimore, Dr.
New Muscle Spasticity Therapy Under Priority Review by FDA
PathMaker Neurosystems Inc., a clinical-stage neuromodulation company focused on non-invasive therapies for neuromotor disorders, recently announced that the…
Potential Multiple Sclerosis Therapy Based on CCR2 Inhibition
New research at the University of Adelaide, Australia, may help pave the way toward the potential inhibition of…
Overcoming Multiple Sclerosis Group Expands into the United States
Overcoming Multiple Sclerosis (OMS), a non-profit organization that promotes a program based on a scientifically tested diet and lifestyle…
Multiple Sclerosis Patients Show Real Gains from Group Exercise Program
Results from a recent study published in the journal Rehabilitation Research and Practice showed the positive effects of…
Multiple Sclerosis Study Explores Fatigue Management in an Organized Program
In a recent study published in the journal BMJ Open, a research team explored the use of…
Multiple Sclerosis Therapeutics’ Market Value to Reach $20B by 2024
RnR Market Research, a company offering market research reports on fields that include healthcare, pharmaceutical, technology, energy, and industry,…
Consortium of Multiple Sclerosis Centers (CMSC) Emphasizes the Role of Physicians in MS Medical Treatment Decisions
The Consortium of Multiple Sclerosis Centers (CMSC), an organization for researchers and healthcare professionals committed to multiple sclerosis (MS)…
2 Forms of Multiple Sclerosis Exhibit Differences in Cognitive Performance Study
In a recent study published in the journal PLOS One, a team of researchers explored the differences…
Multiple Sclerosis Study Pinpoints B Cell Involvement in Disease Development
A recent study published in the journal Science Translational Medicine provided new insights into the role of…
Autoimmune Flare-Ups in Multiple Sclerosis May Be Influenced by Dietary Fat
Results from a recent study published in the journal Immunity indicate that dietary fat has an influence in…
Biogen’s Investment in Multiple Sclerosis Therapies Reinforced in Company Restructuring
Advancing key medicinal treatments like TECFIDERA (dimethyl fumarate), the most prescribed oral treatment for multiple sclerosis (MS), is a key focus…